Abbreviations: HIF1 -Hypoxia-inducible factor 1; ROS -reactive oxygen species; STZStreptozotocin; DPN -Diabetic peripheral neuropathy; DRG -dorsal root ganglia; SNS -sensory neuron-specific Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species.  Activation of HIF1α signaling in diabetic mice protects the sensory neurons by limiting ROS formation generated due to mitochondrial dysfunction.
INTRODUCTION
Diabetes is a chronic progressive metabolic disease characterized by elevated levels of blood glucose. It is one of the largest health care problems worldwide, with more than 422 million diabetic patients 1. Diabetic peripheral neuropathy (DPN) is one of the most common diabetic complications. Patients with DPN experience pain, tingling, prickling sensations and numbness, which can progress to complete loss of sensation and motor dysfunction. These late diabetic complications in combination with vascular damage are the leading cause of lower extremity amputations 2, 3. Clinical research from last two decades indicates that rigorous control of glucose reduces the incidence of DPN, suggesting a major role for hyperglycemia 4.
Uncovering molecular mechanisms underlying DPN remains a major challenge and a lack of mechanistic understanding has long hampered effective therapy of DPN. Only recently, hyperglycemia-induced mitochondrial dysfunction and the subsequent generation of ROS have gained attention as possible mechanisms 5. Prolonged hyperglycemia energizes activation of the polyol 6, and hexosamine pathways 7, activation of PKC isoforms 8 and production of advanced glycation end products (AGE) 9, 10, thereby cumulatively increasing the intracellular ratio of NADH/NAD+. It has been hypothesized that this depletion of cellular antioxidant potential leads to cellular damage, which is marked by the progression of DPN 11. Hyperglycemia-induced ROS formation causes the development of a pseudohypoxia state, which modulates intracellular signaling pathways such as mitogen activation protein kinases (MAPKs), nuclear factor kappa B (NF-B), activator protein I (AP-I) and importantly, hypoxia-inducible factor-1 (HIF-1) 12, 13.
HIF1 is a heterodimeric transcriptional factor composed of  and  subunits (HIF1 and HIF1 respectively) 14, 15. HIF1 is an oxygen-sensitive subunit and its activity is tightly regulated by cellular oxygen concentration 15, while HIF1 is constitutively expressed. In conditions of normoxia, HIF1 is subjected to oxygen-dependent hydroxylation at two prolyl residues, which enables its binding to Hippel-Lindau protein (VHL) leading to polyubiquitination and subsequent proteasomal degradation 16, 17. In contrast, under hypoxic conditions, hydroxylation of HIF1 is inhibited, resulting in accumulation of HIF1 and its heteromerization with HIF1. In consequence, stabilized transcription factor HIF1 binds to hypoxia response elements (HREs) and regulates the expression of target genes, leading to biological consequences.
In contrast to the clarity on hypoxia-mediated modulation of HIF1, the role of hyperglycemia in the modulation of HIF1 is subject to much debate. Previous studies report contradictory observations, e.g. hyperglycemia-induced stabilization of HIF1 in pancreatic cancer cells versus its inhibition in primary dermal fibroblasts 33, 45. Moreover, there is no knowledge on the role of HIF1 in hyperglycemia-induced dysfunction in peripheral sensory neurons in the course of DPN. Recently, it was reported that HIF1 deletion results in exaggerated acute thermal and cold nociception 18 in naïve mice, suggesting that HIF1 activity is important in peripheral nociceptive neurons. However, to date, the role of HIF1 in pathological DPN-related structural and functional changes in peripheral sensory neurons has not been studied.
Here, we investigated the role of HIF1 in peripheral pain-sensing (nociceptive) neurons over the chronic progression of DPN in mice genetically lacking HIF1 conditionally in the dorsal root ganglia (DRG) by undertaking detailed longitudinal analyses spanning 6 months following induction of type1 diabetes in the streptozotocin (STZ) model. Our results uncover a previously undescribed protective role of HIF1 in nerve damage and sensory loss associated with chronic stages of DPN and lead to the surprising observation that HIF1 is an upstream modulator of ROS levels and oxidative stress in peripheral sensory neurons under diabetic conditions.
MATERIAL AND METHODS:

Animal experiments
Age-matched 7-9 wks old SNS-HIF1α -/-and HIF1α fl/fl mice were used for experiments.
Animals were maintained in a temperature controlled room with a light/dark cycle (12/12).
Four to five littermates were housed in individually ventilated cage-rack system (Techniplast, Italy) with free access to water and food. All animal experiments were done in accordance with ethical guidelines and approved by Regierungspräsidium Karlsruhe, Germany.
Sensory-neuron-specific knockout mice
Mice lacking HIF-1α (SNS-HIF1α -/-) in a sensory neuron-specific manner were described previously 18. Blood glucose levels were measured once weekly using a glucometer (Accu-Chek, Roche Diagnostics) for the entire course of the experiment. Mice above > 350 mg/dl were considered to be diabetic. Mice were analyzed over a period of 5 wks to 24 wks post-STZ injection. At 2 weeks (wks) post-STZ injection, we achieved blood glucose between 380 and 500 mg/dl. The blood glucose levels were maintained in a range between 380 and 480 mg/dl by administering insulin sub-cutaneously as required over the entire course of an experiment to ensure uniformity and consistency.
Behavioral measurements
All behavioral experiments were done in awake, unrestrained, acclimatized, age-matched adult mice. Mice were habituated to the experimental setup twice a day for 4 days prior to 
ROS measurements in DRG
To detect production of ROS and superoxide in DRG of SNSHIF1α Further, the sections were washed and mounted in Mowiol. Fluorescence images were obtained using a laser-scanning spectral confocal microscope and maximal projections were created using Leica SP8 software (Leica TCS SP8 AOBS, Bensheim, Germany). Same conditions were used for imaging of sections from control and test groups. The acquired images were analyzed using ImageJ software. The fluorescence intensity from the epidermal area was measured and the background staining from IgG control was deducted from each test sample.
Statistical analysis
All the data were calculated and are presented as mean ± SEM. ANOVA for repeated measures followed by Bonferroni's test for multiple comparisons was employed to determine statistically significant differences. Changes with p ≤ 0.05 were considered to be significant.
RESULTS
In vivo modulation of nociception by HIF1α in STZ model of type 1 diabetes
This study investigated the role of HIF1α in the modulation of levels of ROS in dorsal root ganglia in diabetic and non-diabetic mice. In order to address a potential contribution of 
Manifestation of DPN in SNS-HIF1α -/-mice post-STZ injection
In order to complement behavioral abnormalities with actual changes in nerve morphology, we conducted a detailed neuropathological analysis of changes in epidermal nerve fiber density. We performed immunostaining of markers for nociceptive nerves, such as Calcitonin 
Modulation of ROS levels in DRGs of diabetic mice by HIF1α
Previous studies have established that hyperglycemia modulates the respiratory chain of the mitochondria and augments oxidative stress 29. Overproduction of ROS has been shown to modulate HIF1 function 30, with both positive and negative modulation being reported, and several mechanisms have been proposed 31, 32, 16. Despite these insights on the regulation of HIF1 by ROS, none of the studies investigated the impact of HIF1 function on modulation of ROS levels itself. Therefore, we measured the levels of ROS in vivo in DRG neurons of SNS-HIF1α -/-and control HIF1α fl/fl mice in the basal state (i.e. naïve mice) and at 13 or 24 wks post-STZ treatment. We intrathecally injected MitoTrackerRedCM-H 2 XROS (100 nm, 10 µl), a reporter for ROS generation 22, and observed that STZ-induced DPN was linked to a significant increase in MitoTrackerRedCM-H 2 XROS fluorescence in DRG neurons, suggesting ROS and superoxide build-up (Fig. 3a, b , *, # p<0.0001, ANOVA, Bonferroni's test). Importantly, the extent of ROS and superoxide accumulation was significantly increased in SNS-HIF1α -/-mice as compared to HIF1α fl/fl mice at 13 and 24 wks of STZ injection (Fig. 3a, b) . Thus, a selective deletion of HIF1α resulted in inflated levels of ROS formation in peripheral sensory neurons in vivo at time points, which temporally matched the exacerbation of DPN in SNS-HIF1α -/-mice. HIF1α has only recently been suggested to modulate pain following direct mechanical injury to peripheral nerves 18. However, to date, nothing was known about the role of HIF1α in pain and nerve damage caused by metabolic dysfunction. Indeed, there is a large mechanistic diversity between diverse forms of pathological pain, such as that arising from direct mechanical injury to nerves that is focal and localized versus metabolically-induced nerve dysfunction in the course of diabetes, which is widespread and diffuse. Very little is known about how nerve damage develops under metabolic stress. We hypothesized that HIF1α may be a vital link because it has been reported to be directly regulated by hyperglycemia in some tissues, such as endothelial cells and cardiac myocytes, with both positive and negative modulation being reported 33. Indeed, using highly selective genetic perturbations, we observed that both structural remodeling of nerves and their functionality (via behavioral analysis) were highly affected upon a loss of HIF1α in sensory neurons. 
DISCUSSION
CONCLUSIONS
In summary, this study identifies HIF1 as an important protective molecule against DPNassociated long-term nerve damage and sensory loss. Moreover, we propose that HIF1α functions as an upstream suppressor of ROS levels in sensory neurons. These observations have direct relevance to a highly debilitating and intractable long-term complication of diabetes and hold significance for novel therapeutic measures designed to strengthen the protective role of HIF1 in sensory neurons over chronic diabetes.
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